vs

Side-by-side financial comparison of HARROW, INC. (HROW) and PAMT CORP (PAMT). Click either name above to swap in a different company.

PAMT CORP is the larger business by last-quarter revenue ($141.3M vs $89.1M, roughly 1.6× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -20.7%, a 28.1% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs -15.1%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $-25.0M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -12.0%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

HROW vs PAMT — Head-to-Head

Bigger by revenue
PAMT
PAMT
1.6× larger
PAMT
$141.3M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+48.4% gap
HROW
33.3%
-15.1%
PAMT
Higher net margin
HROW
HROW
28.1% more per $
HROW
7.4%
-20.7%
PAMT
More free cash flow
HROW
HROW
$33.0M more FCF
HROW
$8.1M
$-25.0M
PAMT
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
-12.0%
PAMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
PAMT
PAMT
Revenue
$89.1M
$141.3M
Net Profit
$6.6M
$-29.3M
Gross Margin
79.3%
Operating Margin
17.5%
-27.0%
Net Margin
7.4%
-20.7%
Revenue YoY
33.3%
-15.1%
Net Profit YoY
-2.2%
7.4%
EPS (diluted)
$0.20
$-1.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
PAMT
PAMT
Q4 25
$89.1M
$141.3M
Q3 25
$71.6M
$150.3M
Q2 25
$63.7M
$151.1M
Q1 25
$47.8M
$155.3M
Q4 24
$66.8M
$166.5M
Q3 24
$49.3M
$182.6M
Q2 24
$48.9M
$182.9M
Q1 24
$34.6M
$182.6M
Net Profit
HROW
HROW
PAMT
PAMT
Q4 25
$6.6M
$-29.3M
Q3 25
$1.0M
$-5.6M
Q2 25
$5.0M
$-9.6M
Q1 25
$-17.8M
$-8.1M
Q4 24
$6.8M
$-31.6M
Q3 24
$-4.2M
$2.4M
Q2 24
$-6.5M
$-2.9M
Q1 24
$-13.6M
$281.0K
Gross Margin
HROW
HROW
PAMT
PAMT
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Q1 24
69.5%
Operating Margin
HROW
HROW
PAMT
PAMT
Q4 25
17.5%
-27.0%
Q3 25
20.6%
-3.8%
Q2 25
17.9%
-7.3%
Q1 25
-23.5%
-5.9%
Q4 24
19.3%
-22.6%
Q3 24
2.7%
1.3%
Q2 24
3.1%
-0.4%
Q1 24
-20.0%
-0.4%
Net Margin
HROW
HROW
PAMT
PAMT
Q4 25
7.4%
-20.7%
Q3 25
1.4%
-3.7%
Q2 25
7.8%
-6.4%
Q1 25
-37.2%
-5.2%
Q4 24
10.1%
-19.0%
Q3 24
-8.6%
1.3%
Q2 24
-13.2%
-1.6%
Q1 24
-39.2%
0.2%
EPS (diluted)
HROW
HROW
PAMT
PAMT
Q4 25
$0.20
$-1.38
Q3 25
$0.03
$-0.27
Q2 25
$0.13
$-0.46
Q1 25
$-0.50
$-0.37
Q4 24
$0.19
$-1.44
Q3 24
$-0.12
$0.11
Q2 24
$-0.18
$-0.13
Q1 24
$-0.38
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
PAMT
PAMT
Cash + ST InvestmentsLiquidity on hand
$72.9M
$83.7M
Total DebtLower is stronger
$250.0M
$333.9M
Stockholders' EquityBook value
$52.4M
$210.5M
Total Assets
$399.5M
$697.9M
Debt / EquityLower = less leverage
4.77×
1.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
PAMT
PAMT
Q4 25
$72.9M
$83.7M
Q3 25
$74.3M
$115.6M
Q2 25
$53.0M
$117.3M
Q1 25
$66.7M
$102.7M
Q4 24
$47.2M
$110.7M
Q3 24
$72.6M
$92.3M
Q2 24
$71.0M
$114.0M
Q1 24
$76.0M
$125.8M
Total Debt
HROW
HROW
PAMT
PAMT
Q4 25
$250.0M
$333.9M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
$325.6M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
PAMT
PAMT
Q4 25
$52.4M
$210.5M
Q3 25
$47.0M
$239.5M
Q2 25
$49.7M
$244.9M
Q1 25
$56.5M
$269.6M
Q4 24
$69.7M
$277.5M
Q3 24
$58.0M
$308.9M
Q2 24
$58.5M
$306.7M
Q1 24
$60.6M
$314.6M
Total Assets
HROW
HROW
PAMT
PAMT
Q4 25
$399.5M
$697.9M
Q3 25
$363.1M
$715.2M
Q2 25
$345.0M
$707.9M
Q1 25
$364.2M
$712.6M
Q4 24
$389.0M
$741.7M
Q3 24
$351.5M
$756.7M
Q2 24
$306.6M
$733.5M
Q1 24
$295.5M
$746.4M
Debt / Equity
HROW
HROW
PAMT
PAMT
Q4 25
4.77×
1.59×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
1.17×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
PAMT
PAMT
Operating Cash FlowLast quarter
$8.4M
$-5.8M
Free Cash FlowOCF − Capex
$8.1M
$-25.0M
FCF MarginFCF / Revenue
9.1%
-17.7%
Capex IntensityCapex / Revenue
0.4%
13.6%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$-23.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
PAMT
PAMT
Q4 25
$8.4M
$-5.8M
Q3 25
$16.6M
$5.9M
Q2 25
$-803.0K
$12.2M
Q1 25
$19.7M
$5.0M
Q4 24
$-17.8M
$15.2M
Q3 24
$3.0M
$15.5M
Q2 24
$-2.7M
$18.7M
Q1 24
$-4.6M
$9.6M
Free Cash Flow
HROW
HROW
PAMT
PAMT
Q4 25
$8.1M
$-25.0M
Q3 25
$16.4M
$2.5M
Q2 25
$-969.0K
$5.9M
Q1 25
$19.5M
$-6.8M
Q4 24
$-18.3M
$-39.9M
Q3 24
$2.3M
$-33.6M
Q2 24
$-3.1M
$4.1M
Q1 24
$-4.7M
$-12.2M
FCF Margin
HROW
HROW
PAMT
PAMT
Q4 25
9.1%
-17.7%
Q3 25
22.9%
1.7%
Q2 25
-1.5%
3.9%
Q1 25
40.8%
-4.4%
Q4 24
-27.4%
-24.0%
Q3 24
4.8%
-18.4%
Q2 24
-6.3%
2.2%
Q1 24
-13.6%
-6.7%
Capex Intensity
HROW
HROW
PAMT
PAMT
Q4 25
0.4%
13.6%
Q3 25
0.3%
2.3%
Q2 25
0.3%
4.2%
Q1 25
0.4%
7.6%
Q4 24
0.8%
33.1%
Q3 24
1.2%
26.9%
Q2 24
0.7%
8.0%
Q1 24
0.3%
12.0%
Cash Conversion
HROW
HROW
PAMT
PAMT
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
6.44×
Q2 24
Q1 24
34.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

PAMT
PAMT

Freight Transportation Service$123.1M87%
Fuel Surcharge$18.2M13%

Related Comparisons